{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:37Z","timestamp":1790649877359,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05888-2","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:10:30Z","timestamp":1745989830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Current concepts on pathogenesis, diagnosis and management of hepatic sarcoidosis"],"prefix":"10.1007","volume":"45","author":[{"given":"Nabil","family":"Belfeki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Kammoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouha","family":"Ghriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charif","family":"Eldirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsene","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"issue":"11","key":"5888_CR1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent M, Crouser ED, Grunewald J (2021) Challenges of sarcoidosis and its management. New Engl J Med 9 Sept 385(11):1018\u20131032","journal-title":"New Engl J Med 9 Sept"},{"issue":"5","key":"5888_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","volume":"26","author":"EV Arkema","year":"2020","unstructured":"Arkema EV, Cozier YC (2020) Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med Sept 26(5):527\u2013534","journal-title":"Curr Opin Pulm Med Sept"},{"issue":"21","key":"5888_CR3","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. New Engl J Med 22 Nov 357(21):2153\u20132165","journal-title":"New Engl J Med 22 Nov"},{"key":"5888_CR4","unstructured":"Belfer MH, Stevens RW, Sarcoidosis (1998) Prim Care Rev Afp 1 D\u00e9c 58(9):2041\u20132050"},{"key":"5888_CR5","doi-asserted-by":"crossref","unstructured":"Sedki M, Fonseca N, Santiago P, Diaz L, Garcia-Buitrago M, Mirsaeidi M et al (oct 2019) Hepatic sarcoidosis: natural history and management implications. Front Med (Lausanne) 30:6:232","DOI":"10.3389\/fmed.2019.00232"},{"key":"5888_CR6","doi-asserted-by":"publisher","first-page":"545413","DOI":"10.3389\/fimmu.2020.545413","volume":"11","author":"AK Gerke","year":"2020","unstructured":"Gerke AK (2020) Treatment of sarcoidosis: A multidisciplinary approach. Front Immunol 19 Nov 11:545413","journal-title":"Front Immunol 19 Nov"},{"key":"5888_CR7","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 21 juill,.;6(7):e1000097","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"3","key":"5888_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/oxfordjournals.aje.a121316","volume":"94","author":"AZ Keller","year":"1971","unstructured":"Keller AZ (1971) Hospital, age, Racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol Sept 94(3):222\u2013230","journal-title":"Am J Epidemiol Sept"},{"issue":"8","key":"5888_CR9","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U, Crystal RG, Culver DA, Drent M et al (2016) Sarcoidosis in America. Analysis based on health care use. Annals ATS Ao\u00fbt 13(8):1244\u20131252","journal-title":"Annals ATS Ao\u00fbt"},{"issue":"4","key":"5888_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1665-2681(19)31983-0","volume":"5","author":"A Karagiannidis","year":"2006","unstructured":"Karagiannidis A, Karavalaki M, Koulaouzidis A (2006) Hepatic sarcoidosis. Ann Hepatol 5(4):251\u2013256","journal-title":"Ann Hepatol"},{"issue":"12","key":"5888_CR11","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1111\/j.1572-0241.2008.02202.x","volume":"103","author":"EC Ebert","year":"2008","unstructured":"Ebert EC, Kierson M, Hagspiel KD (2008) Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol D\u00e9c 103(12):3184\u20133192 quiz 3193","journal-title":"Am J Gastroenterol D\u00e9c"},{"key":"5888_CR12","volume-title":"\u00e9diteurs. Harrison\u2019s principles of internal medicine [Internet]. 21e \u00e9d","author":"RP Baughman","year":"2022","unstructured":"Baughman RP, Lower EE (2022) Sarcoidosis. In: Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson JL (eds) \u00e9diteurs. Harrison\u2019s principles of internal medicine [Internet]. 21e \u00e9d. McGraw-Hill Education, New York, NY. [cit\u00e9 16 mars 2024]. Disponible sur: accessmedicine.mhmedical.com\/content.aspx?aid\u2009=\u20091198714730"},{"issue":"6","key":"5888_CR13","doi-asserted-by":"publisher","first-page":"100360","DOI":"10.1016\/j.jhepr.2021.100360","volume":"3","author":"C Graf","year":"2021","unstructured":"Graf C, Arncken J, Lange CM, Willuweit K, Schattenberg JM, Seessle J et al (2021) Hepatic sarcoidosis: clinical characteristics and outcome. JHEP Rep 3 Sept 3(6):100360","journal-title":"JHEP Rep 3 Sept"},{"issue":"1","key":"5888_CR14","doi-asserted-by":"publisher","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","volume":"51","author":"JC Schupp","year":"2018","unstructured":"Schupp JC, Freitag-Wolf S, Bargagli E, Mihailovi\u0107-Vu\u010dini\u0107 V, Rottoli P, Grubanovic A et al (2018) Phenotypes of organ involvement in sarcoidosis. Eur Respir J Janv 51(1):1700991","journal-title":"Eur Respir J Janv"},{"issue":"9","key":"5888_CR15","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1111\/all.13788","volume":"74","author":"K Maeda","year":"2019","unstructured":"Maeda K, Caldez MJ, Akira S (2019) Innate immunity in allergy. Allergy Sept 74(9):1660\u20131674","journal-title":"Allergy Sept"},{"key":"5888_CR16","doi-asserted-by":"crossref","unstructured":"Guo H, Callaway JB, Ting JPY, Inflammasomes (2015) Mechanism of action, role in disease, and therapeutics. Nat Med Juill 21(7):677\u2013687","DOI":"10.1038\/nm.3893"},{"key":"5888_CR17","doi-asserted-by":"crossref","unstructured":"Ruytinx P, Proost P, Van Damme J, Struyf S Chemokine-Induced macrophage polarization in inflammatory conditions. Front Immunol. 7 sept 2018;9:1930.","DOI":"10.3389\/fimmu.2018.01930"},{"issue":"3","key":"5888_CR18","doi-asserted-by":"publisher","first-page":"1900119","DOI":"10.1183\/13993003.00119-2019","volume":"55","author":"C Huppertz","year":"2020","unstructured":"Huppertz C, J\u00e4ger B, Wieczorek G, Engelhard P, Oliver SJ, Bauernfeind FG et al (2020) The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation. Eur Respir J Mars 55(3):1900119","journal-title":"Eur Respir J Mars"},{"key":"5888_CR19","unstructured":"Activation of mucosal -associated invariant T cells in the lungs of sarcoidosis patients - PMC [Internet]. [cit\u00e9 16 mars 2024]. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6742655\/"},{"issue":"4","key":"5888_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","volume":"19","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Cameli P, d\u2019Alessandro M, Vagaggini C, Refini R, Landi C et al (2019) NK and NKT-like cells in granulomatous and fibrotic lung diseases. Clin Exp Med 1 Nov 19(4):487\u2013494","journal-title":"Clin Exp Med 1 Nov"},{"issue":"4","key":"5888_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/qjmed\/hcx243","volume":"111","author":"G Cooke","year":"2018","unstructured":"Cooke G, Kamal I, Strengert M, Hams E, Mawhinney L, Tynan A et al (2018) Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis. QJM Avr 111(4):217\u2013224","journal-title":"QJM Avr"},{"key":"5888_CR22","doi-asserted-by":"publisher","first-page":"3642832","DOI":"10.1155\/2017\/3642832","volume":"2017","author":"C Hawkins","year":"2017","unstructured":"Hawkins C, Shaginurova G, Shelton DA, Herazo-Maya JD, Oswald-Richter KA, Rotsinger JE et al (2017) Local and systemic CD4\u2009+\u2009T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis. J Immunol Res 2017:3642832","journal-title":"J Immunol Res"},{"key":"5888_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rmed.2019.04.005","volume":"152","author":"NK Arger","year":"2019","unstructured":"Arger NK, Ho M, Woodruff PG, Koth LL (2019) Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis. Respir Med Juin 152:89\u201396","journal-title":"Respir Med Juin"},{"issue":"4","key":"5888_CR24","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.alit.2018.02.011","volume":"67","author":"CTH Nguyen","year":"2018","unstructured":"Nguyen CTH, Kambe N, Ueda-Hayakawa I, Kishimoto I, Ly NTM, Mizuno K et al (2018) TARC expression in the circulation and cutaneous granulomas correlates with disease severity and indicates Th2-mediated progression in patients with sarcoidosis. Allergol Int Oct 67(4):487\u2013495","journal-title":"Allergol Int Oct"},{"key":"5888_CR25","doi-asserted-by":"crossref","unstructured":"Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT et al (sept 2018) PD-1 up-regulation on CD4\u2009+\u2009T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-\u03b21 production. Sci Transl Med 26(460):eaar8356","DOI":"10.1126\/scitranslmed.aar8356"},{"issue":"11","key":"5888_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.7150\/ijms.18838","volume":"14","author":"J Ding","year":"2017","unstructured":"Ding J, Dai J, Cai H, Gao Q, Wen Y (2017) Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis. Int J Med Sci 14(11):1136\u20131142","journal-title":"Int J Med Sci"},{"key":"5888_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3389\/fimmu.2017.01130","volume":"8","author":"Y Kaiser","year":"2017","unstructured":"Kaiser Y, Lakshmikanth T, Chen Y, Mikes J, Eklund A, Brodin P et al (2017) Mass cytometry identifies distinct lung CD4\u2009+\u2009T cell patterns in L\u00f6fgren\u2019s syndrome and Non-L\u00f6fgren\u2019s syndrome sarcoidosis. Front Immunol 12 Sept 8:1130","journal-title":"Front Immunol 12 Sept"},{"issue":"1","key":"5888_CR28","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","volume":"10","author":"I Kudryavtsev","year":"2020","unstructured":"Kudryavtsev I, Serebriakova M, Starshinova A, Zinchenko Y, Basantsova N, Malkova A et al (2020) Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis. Sci Rep 23 Janv 10(1):1059","journal-title":"Sci Rep 23 Janv"},{"issue":"10","key":"5888_CR29","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","volume":"37","author":"M Ando","year":"2018","unstructured":"Ando M, Goto A, Takeno Y, Yamasue M, Komiya K, Umeki K et al (2018) Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis. Clin Rheumatol Oct 37(10):2833\u20132838","journal-title":"Clin Rheumatol Oct"},{"issue":"7","key":"5888_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/01.meg.0000223911.85739.38","volume":"18","author":"PTF Kennedy","year":"2006","unstructured":"Kennedy PTF, Zakaria N, Modawi SB, Papadopoulou AM, Murray-Lyon I, du Bois RM et al (2006) Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol Juill 18(7):721\u2013726","journal-title":"Eur J Gastroenterol Hepatol Juill"},{"key":"5888_CR31","doi-asserted-by":"crossref","unstructured":"Nakamura N, Mastsuno Y, Aoi K, Kosaka H, Kobayashi S, Takahashi Y et al (2025) Hepatic sarcoidosis mimicking a metastatic tumor: a case report. Int Med.;advpub","DOI":"10.2169\/internalmedicine.4528-24"},{"issue":"10","key":"5888_CR32","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/ajg.2017.231","volume":"112","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Simonetto DA, Matteson EL (2017) Clinical characteristics and outcome of hepatic sarcoidosis: A Population-Based study 1976\u20132013. Am J Gastroenterol Oct 112(10):1556\u20131563","journal-title":"Am J Gastroenterol Oct"},{"key":"5888_CR33","doi-asserted-by":"crossref","unstructured":"John B, Nagpal S, Plesec T, Jegadeesan R, Lopez R, Alkhouri N et al (2015) Mo1901 Evaluation of Portal Hypertension and Cirrhosis in Patients With Hepatic Sarcoidosis: A Prospective Single Center Study. Gastroenterology. 1 avr.;148:S-1078","DOI":"10.1016\/S0016-5085(15)33683-0"},{"issue":"1","key":"5888_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-2007-970335","volume":"28","author":"MA Judson","year":"2007","unstructured":"Judson MA (2007) Extrapulmonary sarcoidosis. Semin Respir Crit Care Med F\u00e9vr 28(1):83\u2013101","journal-title":"Semin Respir Crit Care Med F\u00e9vr"},{"issue":"3","key":"5888_CR35","first-page":"306","volume":"78","author":"C Bihari","year":"2015","unstructured":"Bihari C, Rastogi A, Kumar N, Rajesh S, Sarin SK (2015) Hepatic sarcoidosis: Clinico-pathological characterization of symptomatic cases. Acta Gastroenterol Belg 78(3):306\u2013313","journal-title":"Acta Gastroenterol Belg"},{"issue":"1","key":"5888_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MEG.0b013e32834c7b71","volume":"24","author":"J Cremers","year":"2012","unstructured":"Cremers J, Drent M, Driessen A, Nieman F, Wijnen P, Baughman R et al (2012) Liver-test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol Janv 24(1):17\u201324","journal-title":"Eur J Gastroenterol Hepatol Janv"},{"issue":"1","key":"5888_CR37","first-page":"73","volume":"14","author":"R Vatti","year":"1997","unstructured":"Vatti R, Sharma OP (1997) Course of asymptomatic liver involvement in sarcoidosis: role of therapy in selected cases. Sarcoidosis Vasc Diffuse Lung Dis Mars 14(1):73\u201376","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Mars"},{"issue":"21","key":"5888_CR38","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.2169\/internalmedicine.51.8224","volume":"51","author":"M Inoue","year":"2012","unstructured":"Inoue M, Chiba T, Zen Y, Yokota H, Kanda T, Ogasawara S et al (2012) Hepatic sarcoidosis with an increased serum level of Immunoglobulin G4. Intern Med 51(21):3095\u20133098","journal-title":"Intern Med"},{"issue":"Pt 1","key":"5888_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/000456328902600102","volume":"26","author":"PR Studdy","year":"1989","unstructured":"Studdy PR, Bird R (1989) Serum angiotensin converting enzyme in sarcoidosis\u2013its value in present clinical practice. Ann Clin Biochem Janv 26(Pt 1):13\u201318","journal-title":"Ann Clin Biochem Janv"},{"issue":"5","key":"5888_CR40","first-page":"A4815","volume":"61","author":"A Fl\u00f8e","year":"2014","unstructured":"Fl\u00f8e A, Hoffmann HJ, Nissen PH, M\u00f8ller HJ, Hilberg O (2014) Genotyping increases the yield of angiotensin-converting enzyme in sarcoidosis\u2013a systematic review. Dan Med J Mai 61(5):A4815","journal-title":"Dan Med J Mai"},{"key":"5888_CR41","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.12659\/AJCR.910600","volume":"19","author":"AM Ibrahim","year":"2018","unstructured":"Ibrahim AM, Bhandari B, Soriano PK, Quader Z, Gao JZ, Shuster D et al (2018) Hepatic involvement in systemic sarcoidosis. Am J Case Rep 11 Oct 19:1212\u20131215","journal-title":"Am J Case Rep 11 Oct"},{"issue":"11","key":"5888_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.revmed.2012.08.007","volume":"33","author":"H Elloumi","year":"2012","unstructured":"Elloumi H, Marzouk S, Tahri N, Bahloul Z, Azouz MM (2012) [Sarcoidosis and liver involvement: a case series of 25 patients]. Rev Med Interne Nov 33(11):607\u2013614","journal-title":"Rev Med Interne Nov"},{"issue":"8","key":"5888_CR43","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1007\/s00261-015-0533-6","volume":"40","author":"AD Karaosmano\u011flu","year":"2015","unstructured":"Karaosmano\u011flu AD, Onur MR, Saini S, Taberi A, Karcaaltincaba M (2015) Imaging of hepatobiliary involvement in sarcoidosis. Abdom Imaging Oct 40(8):3330\u20133337","journal-title":"Abdom Imaging Oct"},{"key":"5888_CR44","doi-asserted-by":"crossref","unstructured":"Ghozy S, Revels JW, Sriwastwa A, Wang LL, Weaver JS, Wang SS Imaging in sarcoid disease. Best Pract Res Clin Rheumatol 14 mars 2025;102054.","DOI":"10.1016\/j.berh.2025.102054"},{"issue":"3","key":"5888_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.mri.2012.08.005","volume":"31","author":"A Ferreira","year":"2013","unstructured":"Ferreira A, Ramalho M, de Campos ROP, Heredia V, Roque A, Vaidean G et al (2013) Hepatic sarcoidosis: MR appearances in patients with chronic liver disease. Magn Reson Imaging Avr 31(3):432\u2013438","journal-title":"Magn Reson Imaging Avr"},{"issue":"5","key":"5888_CR46","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.acra.2014.01.008","volume":"21","author":"G Treglia","year":"2014","unstructured":"Treglia G, Annunziata S, Sobic-Saranovic D, Bertagna F, Caldarella C, Giovanella L (2014) The role of 18F-FDG-PET and PET\/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol Mai 21(5):675\u2013684","journal-title":"Acad Radiol Mai"},{"key":"5888_CR47","doi-asserted-by":"crossref","unstructured":"Spagnolo P, Bernardinello N, Sarcoidosis (2023) Immunol Allergy Clin North Am Mai 43(2):259\u2013272","DOI":"10.1016\/j.iac.2023.01.008"},{"issue":"3","key":"5888_CR48","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/liv.70037","volume":"45","author":"LJ Horst","year":"2025","unstructured":"Horst LJ, Zimmermann K, Lutz J, Weidemann S, L\u00fcth S, Lohse AW et al (2025) Insights into hepatic sarcoidosis: analysis of histological patterns, hepatic complications and therapeutic approaches. Liver Int Mars 45(3):e70037","journal-title":"Liver Int Mars"},{"key":"5888_CR49","doi-asserted-by":"crossref","unstructured":"Zd KD, Ms G, Hj E, Kg Z I. Hepatic sarcoidosis. Clinicopathologic features in 100 patients. The American journal of surgical pathology [Internet]. d\u00e9c 1993 [cit\u00e9 16 mars 2024];17(12). Disponible sur: https:\/\/pubmed.ncbi.nlm.nih.gov\/8238735\/","DOI":"10.1097\/00000478-199312000-00009"},{"issue":"3","key":"5888_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1055\/s-0038-1666853","volume":"38","author":"S Deutsch-Link","year":"2018","unstructured":"Deutsch-Link S, Fortuna D, Weinberg EM (2018) A comprehensive review of hepatic sarcoid. Semin Liver Dis Ao\u00fbt 38(3):284\u2013297","journal-title":"Semin Liver Dis Ao\u00fbt"},{"key":"5888_CR51","doi-asserted-by":"crossref","unstructured":"Ishak KG (1998) Sarcoidosis of the liver and bile ducts. Mayo Clin Proc.;73(5):467\u201372","DOI":"10.1016\/S0025-6196(11)63733-6"},{"issue":"3","key":"5888_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/hep.510260304","volume":"26","author":"F Moreno-Merlo","year":"1997","unstructured":"Moreno-Merlo F, Wanless IR, Shimamatsu K, Sherman M, Greig P, Chiasson D (1997) The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Hepatol Sept 26(3):554\u2013560","journal-title":"Hepatol Sept"},{"issue":"12","key":"5888_CR53","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1440-1746.2008.05707.x","volume":"23","author":"A Malhotra","year":"2008","unstructured":"Malhotra A, Naniwadekar A, Sood G (2008) Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol 23(12):1942\u20131942","journal-title":"J Gastroenterol Hepatol"},{"key":"5888_CR54","unstructured":"Hepatic sarcoidosis with portal hypertension A report of seven cases with a review of the literature - PubMed [Internet]. [cit\u00e9 16 mars 2024]. Disponible sur: https:\/\/pubmed.ncbi.nlm.nih.gov\/3310076\/"},{"issue":"7","key":"5888_CR55","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1440-1746.2003.03335.x","volume":"19","author":"M Blich","year":"2004","unstructured":"Blich M, Edoute Y (2004) Clinical manifestations of sarcoid liver disease. J Gastroenterol Hepatol Juill 19(7):732\u2013737","journal-title":"J Gastroenterol Hepatol Juill"},{"issue":"4","key":"5888_CR56","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1665-2681(19)31983-0","volume":"5","author":"A Karagiannidis","year":"2006","unstructured":"Karagiannidis A, Karavalaki M, Koulaouzidis A (2006) Hepatic sarcoidosis: concise review. Annals Hepatol 1 Oct 5(4):251\u2013256","journal-title":"Annals Hepatol 1 Oct"},{"issue":"6","key":"5888_CR57","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1055\/s-2002-36517","volume":"23","author":"MA Judson","year":"2002","unstructured":"Judson MA (2002) Hepatic, Splenic, and Gastrointestinal involvement with sarcoidosis. Semin Respir Crit Care Med D\u00e9c 23(6):529\u2013541","journal-title":"Semin Respir Crit Care Med D\u00e9c"},{"issue":"10","key":"5888_CR58","first-page":"1743","volume":"113","author":"Y Kunishi","year":"2016","unstructured":"Kunishi Y, Yoshie K, Ota M, Kuboi Y, Kanno M, Tanaka S et al (2016) [Peritoneal sarcoidosis:an unusual cause of Ascites]. Nihon Shokakibyo Gakkai Zasshi 113(10):1743\u20131751","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"5888_CR59","first-page":"995042","volume":"9","author":"M Fauter","year":"2022","unstructured":"Fauter M, Rossi G, Drissi-Bakhkhat A, Latournerie M, Gerfaud-Valentin M, Durieu I et al (2022) Hepatic sarcoidosis with symptomatic portal hypertension: A report of 12 cases with review of the literature. Front Med (Lausanne) 22 D\u00e9c 9:995042","journal-title":"Front Med (Lausanne) 22 D\u00e9c"},{"issue":"1","key":"5888_CR60","first-page":"51","volume":"8","author":"M Yamaguchi","year":"1991","unstructured":"Yamaguchi M, Odaka M, Hosoda Y, Iwai K, Tachibana T (1991) Excess death of lung cancer among sarcoidosis patients. Sarcoidosis Mars 8(1):51\u201355","journal-title":"Sarcoidosis Mars"},{"issue":"5 Pt 1","key":"5888_CR61","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1164\/ajrccm.160.5.9904045","volume":"160","author":"J Askling","year":"1999","unstructured":"Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A (1999) Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med Nov 160(5 Pt 1):1668\u20131672","journal-title":"Am J Respir Crit Care Med Nov"},{"issue":"6","key":"5888_CR62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/SGA.0000000000000692","volume":"45","author":"D Ar\u0131","year":"2022","unstructured":"Ar\u0131 D, Turan G\u00f6k\u00e7e D, \u00d6zt\u00fcrk \u00d6, \u00d6zdemir B, Turhan N, Akdo\u011fan Kayhan M (2022) SYSTEMIC SARCOIDOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A CASE REPORT. Gastroenterol Nurs 1 D\u00e9c 45(6):449\u2013451","journal-title":"Gastroenterol Nurs 1 D\u00e9c"},{"issue":"2","key":"5888_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s002920050200","volume":"18","author":"R Kestlmeier","year":"1997","unstructured":"Kestlmeier R, Busch R, Fellbaum C, Boettcher K, Reich U, Siewert JR et al (1997) [Incidence and prognostic significance of epithelioid cell reactions and microcarcinoses in regional lymph nodes in stomach carcinoma]. Pathologe Mars 18(2):124\u2013130","journal-title":"Pathologe Mars"},{"key":"5888_CR64","doi-asserted-by":"crossref","unstructured":"Ennaifer R, Bacha D, Romdhane H, Cheikh M, Nejma HB, BelHadj N (2015) Budd-Chiari Syndrome: An Unusual Presentation of Multisystemic Sarcoidosis. Clin Pract. 21 d\u00e9c.;5(3):768","DOI":"10.4081\/cp.2015.768"},{"issue":"9","key":"5888_CR65","doi-asserted-by":"publisher","first-page":"e00200","DOI":"10.14309\/crj.0000000000000200","volume":"6","author":"T Odah","year":"2019","unstructured":"Odah T, Al-Khazraji A, Idriss R, Morrow M, Curry MP (2019) Budd-Chiari syndrome in a patient with simultaneous diagnosis of hepatic sarcoidosis and nodular regenerative hyperplasia. ACG Case Rep J 12 Sept 6(9):e00200","journal-title":"ACG Case Rep J 12 Sept"},{"key":"5888_CR66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.11604\/pamj.2016.23.4.8564","volume":"23","author":"IA Sghier","year":"2016","unstructured":"Sghier IA, Billah NM (2016) [Budd-Chiari syndrome: a rare complication of hepatic sarcoidosis (about one case)]. Pan Afr Med J 23:4","journal-title":"Pan Afr Med J"},{"issue":"1","key":"5888_CR67","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L et al (2014) The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 18 Avr 31(1):19\u201327","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis 18 Avr"},{"issue":"3","key":"5888_CR68","doi-asserted-by":"publisher","first-page":"170","DOI":"10.32074\/1591-951X-245","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M et al (2021) Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica Juin 113(3):170\u2013184","journal-title":"Pathologica Juin"},{"issue":"9777","key":"5888_CR69","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","volume":"377","author":"C Selmi","year":"2011","unstructured":"Selmi C, Bowlus CL, Gershwin ME, Coppel RL (2011) Primary biliary cirrhosis. Lancet 7 Mai 377(9777):1600\u20131609","journal-title":"Lancet 7 Mai"},{"issue":"2","key":"5888_CR70","first-page":"87","volume":"1","author":"M Tadros","year":"2013","unstructured":"Tadros M, Forouhar F, Wu GY (2013) Hepatic sarcoidosis. J Clin Transl Hepatol D\u00e9c 1(2):87\u201393","journal-title":"J Clin Transl Hepatol D\u00e9c"},{"issue":"1","key":"5888_CR71","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.revmed.2007.10.003","volume":"29","author":"M Malphettes","year":"2008","unstructured":"Malphettes M, Oksenhendler E, Galicier L, Fieschi C (2008) [Granulomatous disease in common variable immunodeficiency]. Rev Med Interne Janv 29(1):28\u201332","journal-title":"Rev Med Interne Janv"},{"key":"5888_CR72","doi-asserted-by":"crossref","unstructured":"Rossi G, Ziol M, Roulot D, Valeyre D, Mah\u00e9vas M (oct 2020) Hepatic sarcoidosis: current concepts and treatments. Semin respir Crit care med. 41(5):652\u2013658","DOI":"10.1055\/s-0040-1713799"},{"issue":"4","key":"5888_CR73","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cld.2010.07.005","volume":"14","author":"SM Lagana","year":"2010","unstructured":"Lagana SM, Moreira RK, Lefkowitch JH (2010) Hepatic granulomas: pathogenesis and differential diagnosis. Clin Liver Dis Nov 14(4):605\u2013617","journal-title":"Clin Liver Dis Nov"},{"issue":"6","key":"5888_CR74","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","volume":"68","author":"E De Martin","year":"2018","unstructured":"De Martin E, Michot JM, Papouin B, Champiat S, Mateus C, Lambotte O et al (2018) Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors. J Hepatol Juin 68(6):1181\u20131190","journal-title":"J Hepatol Juin"},{"issue":"3","key":"5888_CR75","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1399-3062.2007.00258.x","volume":"10","author":"MI Fiel","year":"2008","unstructured":"Fiel MI, Shukla D, Saraf N, Xu R, Schiano TD (2008) Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl Infect Dis Juin 10(3):184\u2013189","journal-title":"Transpl Infect Dis Juin"},{"key":"5888_CR76","doi-asserted-by":"crossref","unstructured":"Lopetuso LR, Cuomo C, Mignini I, Gasbarrini A, Papa A (2023) Focus on Anti-Tumour Necrosis Factor (TNF)-\u03b1-Related Autoimmune Diseases. Int J Mol Sci. 3 mai.;24(9):8187","DOI":"10.3390\/ijms24098187"},{"issue":"4","key":"5888_CR77","first-page":"316","volume":"28","author":"CY Wu","year":"2020","unstructured":"Wu CY, Wang RC, Chen BJ, Chen WY, Jhuang JY, Chang MC et al (2020) Granuloma with an underlying lymphoma: A diagnostic challenge and a wider histologic spectrum including adult T-Cell leukemia\/lymphoma. Appl Immunohistochem Mol Morphol Avr 28(4):316\u2013324","journal-title":"Appl Immunohistochem Mol Morphol Avr"},{"issue":"9","key":"5888_CR78","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.revmed.2010.06.017","volume":"32","author":"G Geri","year":"2011","unstructured":"Geri G, Cacoub P (2011) [Hepatic granulomas]. Rev Med Interne Sept 32(9):560\u2013566","journal-title":"Rev Med Interne Sept"},{"key":"5888_CR79","doi-asserted-by":"crossref","unstructured":"Saketkoo LA, Russell AM, Jensen K, Mandizha J, Tavee J, Newton J et al (2021) Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes. Diagnostics (Basel). 15 juin.;11(6):1089","DOI":"10.3390\/diagnostics11061089"},{"issue":"2","key":"5888_CR80","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/17512433.2021.1878024","volume":"14","author":"ON Obi","year":"2021","unstructured":"Obi ON, Lower EE, Baughman RP (2021) Biologic and advanced Immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Rev Clin Pharmacol F\u00e9vr 14(2):179\u2013210","journal-title":"Expert Rev Clin Pharmacol F\u00e9vr"},{"issue":"3","key":"5888_CR81","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17476348.2020.1707672","volume":"14","author":"A Pande","year":"2020","unstructured":"Pande A, Culver DA (2020) Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med Mars 14(3):285\u2013298","journal-title":"Expert Rev Respir Med Mars"},{"issue":"3","key":"5888_CR82","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1586\/17474124.2015.958468","volume":"9","author":"J Modaresi Esfeh","year":"2015","unstructured":"Modaresi Esfeh J, Culver D, Plesec T, John B (2015) Clinical presentation and protocol for management of hepatic sarcoidosis. Expert Rev Gastroenterol Hepatol Mars 9(3):349\u2013358","journal-title":"Expert Rev Gastroenterol Hepatol Mars"},{"key":"5888_CR83","unstructured":"Therapeutic approach of hepatic sarcoidosis - PubMed [Internet]. [cit\u00e9 16 mars 2024]. Disponible sur: https:\/\/pubmed.ncbi.nlm.nih.gov\/22617809\/"},{"issue":"3","key":"5888_CR84","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00000441-199003000-00002","volume":"299","author":"EE Lower","year":"1990","unstructured":"Lower EE, Baughman RP (1990) The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci Mars 299(3):153\u2013157","journal-title":"Am J Med Sci Mars"},{"issue":"6","key":"5888_CR85","doi-asserted-by":"publisher","first-page":"2004079","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A et al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J D\u00e9c 58(6):2004079","journal-title":"Eur Respir J D\u00e9c"},{"issue":"2","key":"5888_CR86","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1183\/09031936.00138913","volume":"43","author":"RP Baughman","year":"2014","unstructured":"Baughman RP, Judson MA (2014) Relapses of sarcoidosis: what are they and can we predict who will get them? Eur Respiratory J 1 F\u00e9vr 43(2):337\u2013339","journal-title":"Eur Respiratory J 1 F\u00e9vr"},{"issue":"2","key":"5888_CR87","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R et al (1999) ATS\/ERS\/WASOG statement on sarcoidosis. American thoracic Society\/European respiratory society\/world association of sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis Sept 16(2):149\u2013173","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Sept"},{"issue":"9","key":"5888_CR88","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/gut.32.9.1061","volume":"32","author":"JS de Caestecker","year":"1991","unstructured":"de Caestecker JS, Jazrawi RP, Petroni ML, Northfield TC (1991) Ursodeoxycholic acid in chronic liver disease. Gut Sept 32(9):1061\u20131065","journal-title":"Gut Sept"},{"issue":"8","key":"5888_CR89","first-page":"349","volume":"70","author":"GJ Bakker","year":"2012","unstructured":"Bakker GJ, Haan YCL, Maillette de Buy Wenniger LJ, Beuers U (2012) Sarcoidosis of the liver: to treat or not to treat? Neth J Med Oct 70(8):349\u2013356","journal-title":"Neth J Med Oct"},{"issue":"6","key":"5888_CR90","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11938-006-0004-9","volume":"9","author":"US Ayyala","year":"2006","unstructured":"Ayyala US, Padilla ML (2006) Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol 9(6):475\u2013483","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"3","key":"5888_CR91","doi-asserted-by":"publisher","first-page":"323","DOI":"10.15403\/jgld-4122","volume":"31","author":"J Sollors","year":"2022","unstructured":"Sollors J, Schlevogt B, Schmidt HJ, Woerns MA, Galle PR, Qian Y et al (2022) Management of hepatic sarcoidosis. J Gastrointestin Liver Dis 15 Sept 31(3):323\u2013330","journal-title":"J Gastrointestin Liver Dis 15 Sept"},{"issue":"5","key":"5888_CR92","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00004836-199010000-00014","volume":"12","author":"JR Murphy","year":"1990","unstructured":"Murphy JR, Sjogren MH, Kikendall JW, Peura DA, Goodman Z (1990) Small bile duct abnormalities in sarcoidosis. J Clin Gastroenterol Oct 12(5):555\u2013561","journal-title":"J Clin Gastroenterol Oct"},{"issue":"155","key":"5888_CR93","doi-asserted-by":"publisher","first-page":"190146","DOI":"10.1183\/16000617.0146-2019","volume":"29","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi FF, Baughman RP, Saketkoo LA, Sweiss NJ, Barney JB, Birring SS et al (2020) Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev 31 Mars 29(155):190146","journal-title":"Eur Respir Rev 31 Mars"},{"issue":"4","key":"5888_CR94","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/hep.28966","volume":"65","author":"M Sebode","year":"2017","unstructured":"Sebode M, Weidemann S, Wehmeyer M, Lohse AW, Schramm C (2017) Anti-TNF-\u03b1 for necrotizing sarcoid granulomatosis of the liver. Hepatol Avr 65(4):1410\u20131412","journal-title":"Hepatol Avr"},{"issue":"2","key":"5888_CR95","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","volume":"47","author":"Y Jamilloux","year":"2017","unstructured":"Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, P\u00e9rard L et al (2017) Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. Semin Arthritis Rheum Oct 47(2):288\u2013294","journal-title":"Semin Arthritis Rheum Oct"},{"issue":"12","key":"5888_CR96","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1002\/art.11357","volume":"48","author":"KU Ulbricht","year":"2003","unstructured":"Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha Blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum D\u00e9c 48(12):3542\u20133543","journal-title":"Arthritis Rheum D\u00e9c"},{"issue":"3","key":"5888_CR97","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","volume":"127","author":"JD Doty","year":"2005","unstructured":"Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with Infliximab. Chest Mars 127(3):1064\u20131071","journal-title":"Chest Mars"},{"issue":"4","key":"5888_CR98","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1399-0012.2005.00372.x","volume":"19","author":"EJ Lipson","year":"2005","unstructured":"Lipson EJ, Fiel MI, Florman SS, Korenblat KM (2005) Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant 19(4):487\u2013491","journal-title":"Clin Transplant"},{"issue":"2","key":"5888_CR99","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jceh.2016.02.005","volume":"6","author":"M Bilal","year":"2016","unstructured":"Bilal M, Satapathy SK, Ismail MK, Vanatta JM (2016) Long-Term outcomes of liver transplantation for hepatic sarcoidosis: A single center experience. J Clin Exp Hepatol Juin 6(2):94\u201399","journal-title":"J Clin Exp Hepatol Juin"},{"issue":"12","key":"5888_CR100","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4254\/wjh.v4.i12.402","volume":"4","author":"A Aravinthan","year":"2012","unstructured":"Aravinthan A, Gelson W, Limbu A, Brais R, Richardson P (2012) Hepatic sarcoidosis complicating treatment-naive viral hepatitis. World J Hepatol 27 D\u00e9c 4(12):402\u2013405","journal-title":"World J Hepatol 27 D\u00e9c"},{"issue":"1","key":"5888_CR101","first-page":"93","volume":"82","author":"A Peixoto","year":"2019","unstructured":"Peixoto A, Martins Rocha T, Santos-Antunes J, Aguiar F, Bernardes M, Vaz C et al (2019) Etanercept-induced granulomatous hepatitis as a rare cause of abnormal liver tests. Acta Gastroenterol Belg 82(1):93\u201395","journal-title":"Acta Gastroenterol Belg"},{"issue":"3","key":"5888_CR102","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/his.14000","volume":"76","author":"Y Zen","year":"2020","unstructured":"Zen Y, Chen YY, Jeng YM, Tsai HW, Yeh MM (2020) Immune-related adverse reactions in the hepatobiliary system: second-generation check-point inhibitors highlight diverse histological changes. Histopathology F\u00e9vr 76(3):470\u2013480","journal-title":"Histopathology F\u00e9vr"},{"issue":"8","key":"5888_CR103","doi-asserted-by":"publisher","first-page":"102587","DOI":"10.1016\/j.autrev.2020.102587","volume":"19","author":"M Rubio-Rivas","year":"2020","unstructured":"Rubio-Rivas M, Moreira C, Marcoval J (2020) Sarcoidosis related to checkpoint and BRAF\/MEK inhibitors in melanoma. Autoimmun Reviews 1 Ao\u00fbt 19(8):102587","journal-title":"Autoimmun Reviews 1 Ao\u00fbt"},{"issue":"4","key":"5888_CR104","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.revmed.2022.02.006","volume":"43","author":"P S\u00e8ve","year":"2022","unstructured":"S\u00e8ve P, Jamilloux Y, Bert A, El Jammal T, Valeyre D (2022) [What do the recent recommendations for the diagnosis and treatment of sarcoidosis mean?]. Rev Med Interne Avr 43(4):199\u2013205","journal-title":"Rev Med Interne Avr"},{"issue":"1","key":"5888_CR105","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jhep.2007.08.011","volume":"48","author":"G Malamut","year":"2008","unstructured":"Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS et al (2008) Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol Janv 48(1):74\u201382","journal-title":"J Hepatol Janv"},{"issue":"6","key":"5888_CR106","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5114\/reum.2017.72630","volume":"55","author":"A Masiak","year":"2017","unstructured":"Masiak A, Drobi\u0144ska A, Zdrojewski Z (2017) Hepatic involvement in granulomatosis with polyangiitis\u2013 diagnostic difficulties. Reumatologia 55(6):318\u2013322","journal-title":"Reumatologia"},{"key":"5888_CR107","first-page":"737453","volume":"2014","author":"A Bharti","year":"2014","unstructured":"Bharti A, Meena LP (2014) Systemic lupus erythematosus with hepatosplenic granuloma: a rare case. Case Rep Immunol 2014:737453","journal-title":"Case Rep Immunol"},{"issue":"12","key":"5888_CR108","doi-asserted-by":"publisher","first-page":"300060520972222","DOI":"10.1177\/0300060520972222","volume":"48","author":"K Kang","year":"2020","unstructured":"Kang K, Sun Y, Li YL, Chang B (2020) Pathogenesis of liver injury in Takayasu arteritis: advanced Understanding leads to new horizons. J Int Med Res D\u00e9c 48(12):300060520972222","journal-title":"J Int Med Res D\u00e9c"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05888-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05888-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T09:03:35Z","timestamp":1747991015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05888-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":108,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["5888"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05888-2","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors hereby declare that no part of this manuscript, including the text and graphics, has been copied, reproduced, or published elsewhere in whole or in part. This manuscript is original and has not been submitted for publication to any other journal. This draft, including the text and the graphs, is not cited or published elsewhere. We did not use AI to write or edit graphic.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"Authors declare that they have no conflict of interest. The draft did not have any industry support.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Open access funding options"}}],"article-number":"130"}}